1) Fatty liver disease
脂肪性肝病
1.
Fatty liver disease and primary liver cancer;
脂肪性肝病与原发性肝癌
2.
Objective To study the role of apoptosis of rat liver cell in the pathologic mechanism of fatty liver disease (FLD).
目的 研究细胞凋亡在实验性脂肪性肝病大鼠病理机制中的作用。
3.
Background: The prevalence rate of fatty liver disease(FLD) is increasing today, and it s prevention and therapy also receive more attention.
背景： 近年来脂肪性肝病(fatty liver disease，FLD)患病率呈逐年增高趋势，其防治也逐渐受到重视，但FLD发病机制复杂，迄今仍不明确。
2) fatty liver
脂肪性肝病
1.
Analysis of risk factors for nonalcoholic fatty liver disease in children with simple obesity
肥胖儿童非酒精性脂肪性肝病发病的相关危险因素分析
3) diabetic fatty liver
糖尿病性脂肪肝
1.
Objective: To explore the relation between insulin resistance and diabetic fatty liver and to study the prophylaxis and treatment of diabetic fatty liver with Tang Gan Kang (TGK).
目的：探讨糖尿病性脂肪肝与胰岛素抵抗的关系以及中药糖肝康对糖尿病性脂肪肝胰岛素抵抗的防治作用。
4) Nonalcoholic fatty liver disease
非乙醇性脂肪性肝病
1.
Nonalcoholic fatty liver disease(NAFLD) is a kind of chronic liver disease,whose spectrum of the disease includes simple hepar adiposum,steatohepatitis(NASH),hepatic fibrosis,and cirrhosis.
非乙醇性脂肪性肝病(NAFLD)是一种常见的慢性肝病,其疾病谱包括单纯性脂肪肝、非乙醇性脂肪性肝炎(NASH)、肝纤维化及肝硬化。
2.
Nonalcoholic fatty liver disease(NAFLD)is now recognized as the most common liver disease which does harm to people s health in the world.
非乙醇性脂肪性肝病已成为一种常见的危害人类健康的疾病,早期可以仅出现肝细胞脂肪变性,进一步可发展为脂肪性肝炎、肝纤维化、肝硬化等终末期病变。
5) Nonalcoholic fatty liver disease
非酒精性脂肪性肝病
1.
Analysis of Perilipin and ADRP changes in the nonalcoholic fatty liver disease;
非酒精性脂肪性肝病发生中Perilipin和ADRP表达变化实验研究
2.
Secretory status of pancreas and pathogenesis of insulin resistance in rat with nonalcoholic fatty liver disease;
非酒精性脂肪性肝病大鼠胰腺分泌状态及胰岛素抵抗观察
3.
Nonalcoholic Fatty Liver Disease with Increased Incidence of Metabolic Disorders;
非酒精性脂肪性肝病患者代谢紊乱发病率增高
6) Nonalcoholic fatty liver diseases
非酒精性脂肪性肝病
1.
Therapeutic effect of weight loss combining bicyclol on primary nonalcoholic fatty liver diseases;
减轻体重联合百塞诺治疗非酒精性脂肪性肝病疗效分析
2.
Objetive:To investigate the efficacy and safety of Jianpi Bushen herb in the treatment of nonalcoholic fatty liver diseases(NAFLD).
目的:研究健脾补肾中药治疗非酒精性脂肪性肝病的疗效和安全性。
补充资料：酒精性肝病
酒精性肝病
alcoholic liver disease
由酒精中毒引起肝脏疾病，主要有酒精性脂肪肝、酒精性肝炎及肝硬化。酒精性脂肪肝是因乙醇在肝内代谢为乙醛及乙酸时，辅酶Ⅰ转变为还原辅酶Ⅰ增加，抑制三羧酸循环，肝内脂肪酸合成增多而致脂肪肝。酒精性肝炎为肝细胞肿胀，线粒体变形，胞质中出现乙醇透明小体，肝细胞变性，周围纤维化。严重者可出现小结节性肝硬化。临床常表现为肝肿大，常与病变程度相关，轻者无症状，重者可有肝炎表现。肝硬化者除有一般肝硬化表现外，还有慢性酒精中毒引起的掌挛缩和脑病等表现。无特异性治疗，以高热量平衡饮食、护肝、补充维生素等；肝硬化则同其他肝硬化一样处理。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条